Klaassen, R J <br/><br/>
Losartan, an angiotensin-II receptor antagonist, reduces hematocrits in kidney transplant recipients with posttransplant erythrocytosis.  [electronic resource] 

 -  Transplantation  Sep 1997 
 - 780-2 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0041-1337 
<br/><br/><label>Standard No.: </label>10.1097/00007890-199709150-00023  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Angiotensin Receptor Antagonists<br/>Biphenyl Compounds--pharmacology<br/>Erythrocyte Count--drug effects<br/>Hematocrit<br/>Humans<br/>Imidazoles--pharmacology<br/>Kidney Transplantation--adverse effects<br/>Losartan<br/>Platelet Aggregation Inhibitors--pharmacology<br/>Polycythemia--blood<br/>Tetrazoles--pharmacology